Sheila Frame most recently served as President, Americas of Amryt Pharma until its sale to the Chiesi Group in 2023. Sheila has spent much of her career in executive positions leading the commercialization and growth of several important pharmaceutical products in oncology, immunology, and rare diseases in the US as well as globally.